Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
May 13, 2024
CGD NOTES
May 23, 2024
CGD NOTES
May 31, 2024
TESTIMONY
May 16, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPERS
April 02, 2024
Starting in 2001, duty-free access to U.S. markets under the African Growth and Opportunity Act (AGOA) led to a brief boom in African manufacturing exports, particularly apparel, which then fizzled in the face of unfettered Chinese competition after 2005. The looming expiration of AGOA—and eroding C...
WORKING PAPERS
February 22, 2024
Antibiotic resistance (ABR) already contributes to almost five million deaths per year. Without action, this number will likely rise substantially. We provide the first comprehensive assessment of the economic drivers of ABR, arguing that ABR in large part arises from extensive unresolved market (an...
BRIEFS
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
BRIEFS
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
WORKING PAPERS
June 09, 2022
Does channeling government-to-person (G2P) payments through bank accounts encourage financial inclusion and use? This paper explores the factors that have driven the adoption of digital payments in India by beneficiaries of PMGKY, the large-scale COVID-19 relief program launched in May 2020.
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.